Mr. Maddux, iBio’s Chief Operating Officer, has more than 25 years of global biologics drug development and manufacturing, business development and relationship management experience. During his career, he has served in key roles supporting the licensure and commercial launch of several biopharmaceutical products. Before joining iBio in December 2020, Mr. Maddux was SVP and Chief Manufacturing Officer at Aptevo Therapeutics. Previously, he was VP and Site Director at GlaxoSmithKline, where he led the largest biopharmaceutical development and manufacturing site within the GSK manufacturing network and was instrumental in launching a successful contract development and manufacturing (CDMO) services business.